As of Apr 23
| -0.12 / -1.07%|
The 3 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 15.00, with a high estimate of 22.00 and a low estimate of 11.28. The median estimate represents a +35.38% increase from the last price of 11.08.
The current consensus among 3 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.